Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The IL23R gene is responsible for making the Interleukin 23 receptor
PMID: 24239932
Fellow pharma powerhouse Roche has also jumped into the oral obesity arena with the $2.7 billion acquisition of Carmot Therapeutics in December 2023, giving it access to CT-388 and CT-868, both of which are dual agonists of the GLP-1 and GIP receptors with best-in-class potential for obesity, Roche said at the time
This reflects a broader access problem that disproportionately affects lupus patients because their indication for these medications (managing corticosteroid-induced weight gain and reducing cardiovascular risk in an autoimmune condition) does not fit neatly into approved indication categories
And although she admits to feeling insecuredespite not showing it on airabout jumping headfirst into something so firmly outside her comfort zone, shes committed to becoming a member of this (often, boys) club
US$ 21.92
US$ 20.23
US$ 26.89
US$ 21.68
US$ 22.26
